Literature DB >> 22044967

Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese.

Amit Parikh1, Joshua B Alley, Richard M Peterson, Michael C Harnisch, Jason M Pfluke, Donovan M Tapper, Stephen J Fenton.   

Abstract

BACKGROUND: This study aimed to determine the incidence, etiology, and management options for symptomatic stenosis (SS) after laparoscopic sleeve gastrectomy (LSG).
METHODS: A retrospective study reviewed morbidly obese patients who underwent LSG between October 2008 and December 2010 to identify patients treated for SS.
RESULTS: In this study, 230 patients (83% female) with a mean age of 49.5 years and a mean body mass index (BMI) of 43 kg/m(2) underwent LSG. In 3.5% of these patients (100% female; mean age, 42 years; mean BMI, 42.6 kg/m(2)), SS developed. The LSG procedure was performed using a 36-Fr. bougie and tissue-reinforced staplers. Four patients had segmental staple-line imbrication, and seven patients underwent contrast study, with 71.4% demonstrating a fixed narrowing. Endoscopy confirmed short-segment stenoses: seven located at mid-body and one located near the gastroesophageal junction. Endoscopic management was 100% successful. The mean number of dilations was 1.6, and the median balloon size was 15 mm. The mean time from surgery to initial endoscopic intervention was 48.8 days, and the mean time from the first dilation to toleration of a solid diet was 49.6 days. Two patients were referred to our institution after undergoing LSG at another facility. The mean time to the transfer was 28.5 days. The two patients had a mean age of 35 years and a mean BMI of 42.3 kg/m(2). Both patients experienced immediate SS after perioperative complications comprising one staple-line hematoma and one leak. Contrast studies demonstrated minimal passage of contrast through a long-segment stenosis. Both patients underwent multiple endoscopic dilation procedures and endoluminal stenting, ultimately requiring laparoscopic conversion to Roux-en-Y gastric bypass. The mean time from the initial surgery to the surgical revision was 77 days, and the mean time after the first intervention to tolerance of a solid diet was 82 days.
CONCLUSION: Symptomatic short-segment stenoses after LSG may be treated successfully with endoscopic balloon dilation. Long-segment stenoses that do not respond to endoscopic techniques may ultimately require conversion to Roux-en-Y gastric bypass.

Entities:  

Mesh:

Year:  2011        PMID: 22044967     DOI: 10.1007/s00464-011-1945-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Strictures after laparoscopic sleeve gastrectomy.

Authors:  Natan Zundel; Juan D Hernandez; Manoel Galvao Neto; Josemberg Campos
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2010-06       Impact factor: 1.719

2.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

3.  Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss.

Authors:  Mathieu D'Hondt; Sofie Vanneste; Hans Pottel; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

4.  Biliopancreatic Diversion with a New Type of Gastrectomy.

Authors: 
Journal:  Obes Surg       Date:  1993-02       Impact factor: 4.129

5.  Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing three different techniques.

Authors:  Giovanni Dapri; Guy Bernard Cadière; Jacques Himpens
Journal:  Obes Surg       Date:  2009-12-11       Impact factor: 4.129

6.  Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow-up of 1 year.

Authors:  Evangelos Menenakos; Konstantinos M Stamou; Konstantinos Albanopoulos; Joanna Papailiou; Demetrios Theodorou; Emmanuel Leandros
Journal:  Obes Surg       Date:  2009-07-28       Impact factor: 4.129

7.  Use of endoscopic stents to treat anastomotic complications after bariatric surgery.

Authors:  Steve Eubanks; Christopher A Edwards; Nicole M Fearing; Archana Ramaswamy; Roger A de la Torre; Klaus J Thaler; Brent W Miedema; James S Scott
Journal:  J Am Coll Surg       Date:  2008-05       Impact factor: 6.113

8.  Experience with laparoscopic sleeve gastrectomy for morbid versus super morbid obesity.

Authors:  Nobumi Tagaya; Kazunori Kasama; Rie Kikkawa; Eiji Kanahira; Akiko Umezawa; Takashi Oshiro; Yuka Negishi; Yoshimochi Kurokawa; Tetsuya Nakazato; Keiichi Kubota
Journal:  Obes Surg       Date:  2008-12-09       Impact factor: 4.129

Review 9.  Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese.

Authors:  O N Tucker; S Szomstein; R J Rosenthal
Journal:  J Gastrointest Surg       Date:  2008-02-09       Impact factor: 3.452

10.  Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (LSG) as an isolated operation.

Authors:  Bettina Uglioni; Bettina Wölnerhanssen; Thomas Peters; Caroline Christoffel-Courtin; Beatrice Kern; Ralph Peterli
Journal:  Obes Surg       Date:  2009-01-24       Impact factor: 4.129

View more
  41 in total

1.  Gastric remnant twist in the immediate post-operative period following laparoscopic sleeve gastrectomy.

Authors:  Gokulakkrishna Subhas; Anupam Gupta; Mubashir Sabir; Vijay K Mittal
Journal:  World J Gastrointest Surg       Date:  2015-11-27

Review 2.  [Stenosis and ulceration after bariatric surgery].

Authors:  S Müller; N Runkel
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

3.  Laparoscopic management of persistent strictures after laparoscopic sleeve gastrectomy.

Authors:  Ramon Vilallonga; Jacques Himpens; Simon van de Vrande
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

4.  Complications associated with laparoscopic sleeve gastrectomy for morbid obesity: a surgeon's guide.

Authors:  Kourosh Sarkhosh; Daniel W Birch; Arya Sharma; Shahzeer Karmali
Journal:  Can J Surg       Date:  2013-10       Impact factor: 2.089

5.  The role of endoscopy in the bariatric surgery patient.

Authors: 
Journal:  Surg Endosc       Date:  2015-05       Impact factor: 4.584

6.  Functional Lumen Imaging Probe Is Useful for the Quantification of Gastric Sleeve Stenosis and Prediction of Response to Endoscopic Dilation: a Pilot Study.

Authors:  Jessica X Yu; Jason R Baker; Lydia Watts; Oliver A Varban; Joan W Chen; Joel H Rubenstein; Allison R Schulman
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

7.  Safety and Efficacy of Endoscopically Secured Fully Covered Self-Expandable Metallic Stents (FCSEMS) for Post-Bariatric Complex Stenosis.

Authors:  Lea Fayad; Cem Simsek; Roberto Oleas; Yervant Ichkhanian; Georges E Fayad; Saowanee Ngamreungphong; Michael Schweitzer; Andreas Oberbach; Anthony N Kalloo; Mouen A Khashab; Vivek Kumbhari
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

8.  Trends in Utilization and Relative Complication Rates of Bariatric Procedures.

Authors:  Ann Y Chung; Paula D Strassle; Francisco Schlottmann; Marco G Patti; Meredith C Duke; Timothy M Farrell
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

9.  Endoscopic management of post-laparoscopic sleeve gastrectomy stenosis.

Authors:  Valérie Deslauriers; Amélie Beauchamp; Fabio Garofalo; Henri Atlas; Ronald Denis; Pierre Garneau; Radu Pescarus
Journal:  Surg Endosc       Date:  2017-07-19       Impact factor: 4.584

10.  Evolving endoscopic management options for symptomatic stenosis post-laparoscopic sleeve gastrectomy for morbid obesity: experience at a large bariatric surgery unit in New Zealand.

Authors:  Ravinder Ogra; Geogry Peter Kini
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.